Wen Hwa Lee, CEO and Chief Scientist at AAAMD, discusses the use of AI in ophthalmology and drug discovery. He started as a molecular biologist and joined AAAMD to develop new approaches to slow down AMD. Challenges in utilizing AI in healthcare and ophthalmology include data fragmentation and standardization, which AAAMD addresses through participant-centric data aggregation. Lee discusses gaps in healthcare data, emphasizing the need for early intervention and preventive healthcare. He outlines multi-sector collaborations, ethical considerations, and data privacy concerns in AI-driven research. Lee focuses on the future of healthcare data aggregation and the practical implementation of AI-driven drug discovery in ophthalmology. He advises researchers to prioritize interdisciplinary collaboration and ethical data practices.
Source link
AI Integration in the Fight Against Age-Related Macular Degeneration
